Thermaquil, Inc.

Philadelphia, PA · Founded 2017 · Medtech · Private

Minimally invasive thermal nerve block device that uses controlled warming and cooling to reversibly block pain signals in nerves, eliminating need for opioids post-surgery

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Philadelphia, PA
Founded
2017
Latest Form D
$405K, Mar 2019
Total capital
$4.6M
Federal grants
$4.2M
7 awards · 2019–2022
Rank in peer group#203 of 538
Private capital raised
$405K
1 Form D · last Mar 2019
91 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

2019202020212022FEDERAL ↑EQUITY ↓Cumulative $4.6M$225K$499K$554K$1.2M$998K$678K1st Form D$405K
2019202020212022FEDERAL ↑EQUITY ↓Cumulative $4.6M$554K$1.2M$998K$678K1st Form D$405K

Latest events

  • Federal grantHealth and Human S · Phase II · Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches$678K
  • Federal grantHealth and Human S · Phase II · Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches$998K
  • Federal grantNSF · Phase II · SBIR Phase II: Drug Free Noninvasive Occipital Nerve Block Device to Reduce Opiate Prescriptions$1.2M
  • Federal grantHealth and Human S · Phase I · Customer discovery for minimally invasive nerve block device to treat severe pain and reduce usage of opiates$55K
  • Federal grantHealth and Human S · Phase I · Customer discovery for minimally invasive nerve block device to treat severe pain and reduce usage of opiates$554K
  • Federal grantHealth and Human S · Phase I · Minimally Invasive Intercostal Nerve Block Device to Treat Severe Pain and Reduce Usage of Opiates$499K
  • Federal grantNSF · Phase I · STTR Phase I: Minimally-invasive reversible thermal nerve block for relief of severe pain$225K
  • Private capital raisedForm D · SEC · 1st filing$405K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#203 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Stephen R. PopielarskiResearcherExecutive Officer, DirectorLinked by $3.1M in grants as PI
  • Tai R. ChangfengResearcherDirectorLinked by $499K in grants as PI

What it has protected

USPTO · 0 granted of 3
  • PendingDevice and Method for Nerve Block by Local CoolingUSPTOApplication 63554311
  • PendingApparatus And Method For Thermal Blockade Of NervesUSPTOApplication 62949969
  • PendingSystems And Methods For Thermal Blockade Of NervesUSPTOApplication PCTUS2019038065

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .